ENSG00000147873 (IFNA5)

homo sapiens

interferon alpha 5

Filter your results

Homo sapiens
Organism part
Showing 9 experiments:
Created with Highcharts 6.2.0adiposebraindorsal thalamusgall bladderlungovarysalivary glandtelencephalonvermiform appendixanimal ovaryatrium auricular regioncerebellar hemispherecolonendometriumfallopian tubehippocampal formationleft cardiac atriummiddle frontal gyrusnucleus accumbenspineal bodyprostate glandskinstomachtibial arteryurinary bladder
T
GTEX - organism part
T
32 Uhlen's Lab
T
Mammalian Kaessmann
T
Hallstrom et al., 2014 - Organism part
T
Illumina Body Map
T
HDBR developing brain - 14 post …
T
HDBR developing brain - 10 post …
T
ENCODE (M. Snyder lab)
T
68 FANTOM5 project - adult
P
Proteomics
T
Transcriptomics
High
Medium
Low
Below cutoff
No data available

Filter your results

Kingdom
Species
Experiment type
Experimental variables
Regulation
-1.1
-5.2
1.1
7.9
Display log2-fold change
Download results
Log2-fold changeSpeciesGene nameComparisonExperimental variablesExperiment name
Adjusted p-valueLog2-fold change
1.2146 × 10-47.9
IFNA5'Newcastle disease virus' at '14 hour' vs 'none' at '0 hour'infect, timeTranscription profiling by array of human dendritic cells infected with Newcastle Disease Virus
Adjusted p-valueLog2-fold change
1.0379 × 10-47.8
IFNA5'Newcastle disease virus' at '16 hour' vs 'none' at '0 hour'infect, timeTranscription profiling by array of human dendritic cells infected with Newcastle Disease Virus
Adjusted p-valueLog2-fold change
9.7397 × 10-57.7
IFNA5'Newcastle disease virus' at '12 hour' vs 'none' at '0 hour'infect, timeTranscription profiling by array of human dendritic cells infected with Newcastle Disease Virus
Adjusted p-valueLog2-fold change
1.3293 × 10-36.8
IFNA5'Newcastle disease virus' at '18 hour' vs 'none' at '0 hour'infect, timeTranscription profiling by array of human dendritic cells infected with Newcastle Disease Virus
Adjusted p-valueLog2-fold change
1.3706 × 10-35.7
IFNA5'Newcastle disease virus' at '10 hour' vs 'none' at '0 hour'infect, timeTranscription profiling by array of human dendritic cells infected with Newcastle Disease Virus
Adjusted p-valueLog2-fold change
2.4308 × 10-35.6
IFNA5'Newcastle disease virus' at '10 hour' vs 'none' at '10 hour'infect, timeTranscription profiling by array of human dendritic cells infected with Newcastle Disease Virus
Adjusted p-valueLog2-fold change
8.0711 × 10-85.5
IFNA5'poly(I:C); 25 microgram per milliliter' vs 'none' in 'none; none'compound, infect, stimulusRNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C.
Adjusted p-valueLog2-fold change
7.3176 × 10-10-5.2
IFNA5'Influenza A virus (A/California/07-00001/2009(H1N1))' vs 'none' in 'poly(I:C); 25 microgram per milliliter; none'compound, infect, stimulusRNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C.
Adjusted p-valueLog2-fold change
6.1957 × 10-54.4
IFNA5'ssON; 0.5 micromolar' vs 'none' in 'none; none'compound, infect, stimulusRNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C.
Adjusted p-valueLog2-fold change
8.1016 × 10-54.4
IFNA5'3 h DRB 0 min 4sU' vs 'untreated'treatment4sUDRB-seq: measuring transcription elongation and initiation genomewide
Adjusted p-valueLog2-fold change
1.4627 × 10-63.9
IFNA5'ssON; 0.5 micromolar' vs 'none' in 'none; Influenza A virus (A/California/07-00001/2009(H1N1))'compound, infect, stimulusRNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C.
Adjusted p-valueLog2-fold change
1.2565 × 10-103.8
IFNA5'Orientia tsutsugamushi infection' vs 'none'stimulusTranscription profiling by array of monocyte-derived dendritic cells stimulated by intracellular bacteria (T. whipplei, B. abortus, C. burnetii, O. tsutsugamushi), lipopolysaccharide against unstimulated controls
Adjusted p-valueLog2-fold change
3.4057 × 10-73.7
IFNA5'ochratoxin A; 130 nanomolar' vs 'none' at '1 day'compound, timeMicroarray mRNA data of RPTEC/TERT1 cells exposed to nephrotoxic chemicals ochratoxin A and potassium bromate
Adjusted p-valueLog2-fold change
4.7938 × 10-7-3.4
IFNA5'poly(I:C); 25 microgram per milliliter' vs 'none' in 'Influenza A virus (A/California/07-00001/2009(H1N1)); ssON; 0.5 micromolar'compound, infect, stimulusRNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C.
Adjusted p-valueLog2-fold change
3.0121 × 10-3-3.4
IFNA5'actinic keratosis' vs 'normal'block, diseaseRNA-seq of a panel of non-melanoma skin cancer lesions
Adjusted p-valueLog2-fold change
7.6565 × 10-3-3.3
IFNA5'squamous cell carcinoma' vs 'normal'block, diseaseRNA-seq of a panel of non-melanoma skin cancer lesions
Adjusted p-valueLog2-fold change
9.7551 × 10-3-3.1
IFNA5'sebaceous of Jadassohn nevus' vs 'normal'block, diseaseRNA-seq of a panel of non-melanoma skin cancer lesions
Adjusted p-valueLog2-fold change
5.4366 × 10-3-2.9
IFNA5'COVID-19' vs 'normal' in 'colon'disease, organism partLung and colon transcriptome profiling of fatal COVID-19 cases
Adjusted p-valueLog2-fold change
1.7936 × 10-22.4
IFNA5'ssON; 0.5 micromolar' vs 'none' in 'poly(I:C); 25 microgram per milliliter; Influenza A virus (A/California/07-00001/2009(H1N1))'compound, infect, stimulusRNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C.
Adjusted p-valueLog2-fold change
4.6092 × 10-3-2.2
IFNA5'neoplasm' vs 'normal tissue adjacent to neoplasm'sampling siteGlobal gene expression profiles of 10 gastric cancer (GC) samples and 10 gastric normal adjacent tissue (gNAT) samples
Adjusted p-valueLog2-fold change
2.2034 × 10-2-2.1
IFNA5'injected in NSG-HLA-A2/HHD mouse' vs 'none' in 'none'stimulus, xenograftRNA-Seq of T cells sorted from human PBMCs, or from T cells stimulated with CD3/CD28 beads for 4 days, or from the spleen of NSG or NSG-HLA-A2/HHD mice, 7 days after transplantation with human PBMCs
Adjusted p-valueLog2-fold change
3.0549 × 10-2-2.1
IFNA5'CD3/CD28 beads' vs 'none' in 'none'stimulus, xenograftRNA-Seq of T cells sorted from human PBMCs, or from T cells stimulated with CD3/CD28 beads for 4 days, or from the spleen of NSG or NSG-HLA-A2/HHD mice, 7 days after transplantation with human PBMCs
Adjusted p-valueLog2-fold change
3.3457 × 10-2-2
IFNA5'injected in NSG mouse' vs 'none' in 'none'stimulus, xenograftRNA-Seq of T cells sorted from human PBMCs, or from T cells stimulated with CD3/CD28 beads for 4 days, or from the spleen of NSG or NSG-HLA-A2/HHD mice, 7 days after transplantation with human PBMCs
Adjusted p-valueLog2-fold change
1.8227 × 10-51.6
IFNA5'ochratoxin A; 130 nanomolar' vs 'none' at '3 day'compound, timeMicroarray mRNA data of RPTEC/TERT1 cells exposed to nephrotoxic chemicals ochratoxin A and potassium bromate
Adjusted p-valueLog2-fold change
3.3773 × 10-41.1
IFNA5'human metapneumovirus' at '48 hour' vs 'none' at '48 hour'infect, timeTranscription profiling by array of human bronchiole epithelial cells infected with human metapneumovirus
Adjusted p-valueLog2-fold change
1.3121 × 10-2-1.1
IFNA5'lesion' vs 'normal tissue adjacent to lesion' in '1 week'sampling site, timeRNA-sequencing of the mRNA transcriptome in lesional and non-lesional skin, across three time-points in severe psoriasis patients treated with the tumor necrosis factor (TNF) inhibitor, etanercept